New strategy aims to cut unneeded prostate biopsies in half
Diagnosis
Recruiting now
This study tests a new way to decide who needs a prostate biopsy. Instead of relying only on MRI, it adds a blood test called Prostate Health Index (PHI) to better tell which men have dangerous prostate cancer. The goal is to safely skip biopsies in men with low-risk findings, re…
Phase: NA • Sponsor: In Gab Jeong, MD • Aim: Diagnosis
Last updated Jun 27, 2026 11:02 UTC